71 related articles for article (PubMed ID: 23531031)
1. Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.
Pugliese M; Fortunati N; Germano A; Asioli S; Marano F; Palestini N; Frairia R; Boccuzzi G; Catalano MG
Thyroid; 2013 Jul; 23(7):838-46. PubMed ID: 23531031
[TBL] [Abstract][Full Text] [Related]
2. Robust Thyroid Gene Expression and Radioiodine Uptake Induced by Simultaneous Suppression of BRAF V600E and Histone Deacetylase in Thyroid Cancer Cells.
Cheng W; Liu R; Zhu G; Wang H; Xing M
J Clin Endocrinol Metab; 2016 Mar; 101(3):962-71. PubMed ID: 26751190
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ALK-Signaling Overcomes STRN-ALK-Induced Downregulation of the Sodium Iodine Symporter and Restores Radioiodine Uptake in Thyroid Cells.
Nikitski AV; Condello V; Divakaran SS; Nikiforov YE
Thyroid; 2023 Apr; 33(4):464-473. PubMed ID: 36585857
[No Abstract] [Full Text] [Related]
4. Combined Vorinostat and Chloroquine Inhibit Sodium-Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo.
Read ML; Brookes K; Zha L; Manivannan S; Kim J; Kocbiyik M; Fletcher A; Gorvin CM; Firth G; Fruhwirth GO; Nicola JP; Jhiang S; Ringel MD; Campbell MJ; Sunassee K; Blower PJ; Boelaert K; Nieto HR; Smith VE; McCabe CJ
Clin Cancer Res; 2024 Apr; 30(7):1352-1366. PubMed ID: 37921808
[TBL] [Abstract][Full Text] [Related]
5. Lack of therapeutic effect of the histone deacetylase inhibitor vorinostat in patients with metastatic radioiodine-refractory thyroid carcinoma.
Woyach JA; Kloos RT; Ringel MD; Arbogast D; Collamore M; Zwiebel JA; Grever M; Villalona-Calero M; Shah MH
J Clin Endocrinol Metab; 2009 Jan; 94(1):164-70. PubMed ID: 18854394
[TBL] [Abstract][Full Text] [Related]
6. Regulation of iodine-glucose flip-flop in SW1736 anaplastic thyroid cancer cell line.
Heydarzadeh S; Moshtaghie AA; Daneshpour M; Hedayati M
J Endocrinol Invest; 2024 May; ():. PubMed ID: 38698299
[TBL] [Abstract][Full Text] [Related]
7. A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid Cancer.
Lechner MG; Brent GA
Clin Cancer Res; 2024 Apr; 30(7):1220-1222. PubMed ID: 38197869
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors.
Gigliotti CL; Ferrara B; Occhipinti S; Boggio E; Barrera G; Pizzimenti S; Giovarelli M; Fantozzi R; Chiocchetti A; Argenziano M; Clemente N; Trotta F; Marchiò C; Annaratone L; Boldorini R; Dianzani U; Cavalli R; Dianzani C
Drug Deliv; 2017 Nov; 24(1):670-680. PubMed ID: 28368209
[TBL] [Abstract][Full Text] [Related]
9. Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation.
Su JY; Huang T; Zhang JL; Lu JH; Wang ML; Yan J; Lin RB; Lin SY; Wang J
Am J Cancer Res; 2024; 14(2):407-428. PubMed ID: 38455407
[TBL] [Abstract][Full Text] [Related]
10. A novel hNIS/tdTomato fusion reporter for visualizing the relationship between the cellular localization of sodium iodide symporter and its iodine uptake function under heat shock treatment.
Yeom CJ; Chung T; Youn H; Kang KW; Lee DS; Chung JK
Mol Imaging; 2015; 14():. PubMed ID: 25773964
[TBL] [Abstract][Full Text] [Related]
11. Modulation of sodium iodide symporter in thyroid cancer.
Lakshmanan A; Scarberry D; Shen DH; Jhiang SM
Horm Cancer; 2014 Dec; 5(6):363-73. PubMed ID: 25234361
[TBL] [Abstract][Full Text] [Related]
12. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.
D'Agostino M; Sponziello M; Puppin C; Celano M; Maggisano V; Baldan F; Biffoni M; Bulotta S; Durante C; Filetti S; Damante G; Russo D
J Mol Endocrinol; 2014 Apr; 52(2):121-31. PubMed ID: 24353283
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer.
Zhang Z; Liu D; Murugan AK; Liu Z; Xing M
Endocr Relat Cancer; 2014 Apr; 21(2):161-73. PubMed ID: 24243688
[TBL] [Abstract][Full Text] [Related]
14. Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy/internal irradiation combination therapy.
Wang C; Li N; Li Y; Hou S; Zhang W; Meng Z; Wang S; Jia Q; Tan J; Wang R; Zhang R
J Nanobiotechnology; 2022 May; 20(1):247. PubMed ID: 35642064
[TBL] [Abstract][Full Text] [Related]
15. Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?
Fuziwara CS; de Mello DC; Kimura ET
Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159110
[TBL] [Abstract][Full Text] [Related]
16. Targeting non-canonical pathways as a strategy to modulate the sodium iodide symporter.
Read ML; Brookes K; Thornton CEM; Fletcher A; Nieto HR; Alshahrani M; Khan R; Borges de Souza P; Zha L; Webster JRM; Alderwick LJ; Campbell MJ; Boelaert K; Smith VE; McCabe CJ
Cell Chem Biol; 2022 Mar; 29(3):502-516.e7. PubMed ID: 34520744
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS.
Oh JM; Ahn BC
Theranostics; 2021; 11(13):6251-6277. PubMed ID: 33995657
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?
Volante M; Lam AK; Papotti M; Tallini G
Endocr Pathol; 2021 Mar; 32(1):63-76. PubMed ID: 33543394
[TBL] [Abstract][Full Text] [Related]
19. Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer.
Choi YJ; Lee JE; Ji HD; Lee BR; Lee SB; Kim KS; Lee IK; Chin J; Cho SJ; Lee J; Lee SW; Ha JH; Jeon YH
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499100
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome.
Boufraqech M; Nilubol N
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31835496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
